Cargando…
SAT134 CGM Use During Pregnancy Complicated By CF-Induced Diabetes
Disclosure: A.Y. Mazori: None. E.S. Markovic: None. C.J. Levy: Advisory Board Member; Self; Dexcom, Eli Lilly & Company. Research Investigator; Self; Abbott Laboratories, Insulet Corporation, Tandem Diabetes Care, Dexcom. Introduction: Glycemic control remains challenging in pregnancies complica...
Autores principales: | Mazori, Alon Y, Markovic, Emily S, Levy, Carol J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555125/ http://dx.doi.org/10.1210/jendso/bvad114.999 |
Ejemplares similares
-
SAT115 Diabetes In Pregnancy: Evaluating Access And Usage Of Continuous Glucose Monitors (CGM) In A Medicaid Population
por: Chilukuri, Pranaya, et al.
Publicado: (2023) -
ODP242 Safety of SGLT2-Inhibitors in Patients with Multiple Myeloma and Diabetes
por: Shyu, Margaret, et al.
Publicado: (2022) -
SAT-649 Comparison of the Accuracy and Concordance of 3 CGM Devices vs SMBG During Aerobic Exercise
por: Henske, Joseph A, et al.
Publicado: (2020) -
SAT099 Should We Use HbA1c Or Continuous Glucose Monitoring (CGM) For Treatment Adjustment In Type 2 Diabetes Non-insulin Treated Patients?
por: Totomirova, Tzvetelina, et al.
Publicado: (2023) -
PSUN229 Transitions of Care and Readmissions in Patients with Diabetes Receiving CGM at Hospital Discharge
por: Barnett, Anne, et al.
Publicado: (2022)